Instil Bio
Instil Bio is a clinical-stage biopharmaceutical company developing novel therapies for diseases with significant unmet medical needs, including non-small cell lung cancer.
Company Overview
Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The company aims to create innovative treatment options by in-licensing and acquiring new therapeutic candidates. These efforts are particularly geared towards addressing diseases with significant unmet medical needs.
Therapeutic Focus
Instil Bio is dedicated to creating novel therapies that target diseases with substantial unmet medical needs. This includes developing therapeutic candidates through in-licensing and acquisition, aiming to provide new hope and options for patients who currently have limited treatments available.
Pipeline Therapies
Instil Bio's development pipeline includes therapies currently in clinical stages for diseases such as non-small cell lung cancer. These therapies are designed to address critical gaps in existing treatment options and improve patient outcomes.